Allele Biotechnology & Pharmaceuticals, Inc. has purchased a new facility for the cGMP production of clinical-grade cells for cell therapy applications. Cells will be produced by Allele for industrial and academic partnerships, as well as its own efforts in the area of cellular therapeutics. The 18,000 sq.-ft. facility, located near its headquarters in San Diego, CA, will be the center of production of human induced pluripotent stem cells (hiPSCs) using its synthetic mRNA platform technol...